Literature DB >> 20351063

A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes.

Kwang-Hoon Song1, Tiangang Li, Erika Owsley, John Y L Chiang.   

Abstract

Cholesterol 7alpha-hydroxylase (CYP7A1) plays a critical role in regulation of bile acid synthesis in the liver. CYP7A1 mRNAs have very short half-lives, and bile acids destabilize CYP7A1 mRNA via the 3'-untranslated region (3'-UTR). However, the underlying mechanism of translational regulation of CYP7A1 mRNA remains unknown. Screening of a human micro RNA (miRNA) microarray has identified five differentially expressed miRNAs in human primary hepatocytes treated with chenodeoxycholic acid, GW4064, or fibroblast growth factor (FGF)19. These compounds also significantly induced the expression of miR-122a, a liver-specific and the predominant miRNA in human hepatocytes. The putative recognition sequences for miR-122a and miR-422a were localized in the 3'-UTR of human CYP7A1 mRNA. The miR-122a and miR-422a mimics inhibited, whereas their inhibitors stimulated CYP7A1 mRNA expression. These miRNAs specifically inhibited the activity of the CYP7A1-3'-UTR reporter plasmids, and mutations of miRNA binding sites in 3'-UTR abrogated miRNA inhibition of reporter activity. These results suggest that miR-122a and miR-422a may destabilize CYP7A1 mRNA to inhibit CYP7A1 expression. However, these miRNAs did not play a role in mediating FGF19 inhibition of CYP7A1 transcription. Under certain conditions, miRNA may reduce CYP7A1 mRNA stability to inhibit bile acid synthesis, and the miR-122a antagomirs may stimulate bile acid synthesis to reduce serum cholesterol and triglycerides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351063      PMCID: PMC2903801          DOI: 10.1194/jlr.M004531

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

3.  miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Authors:  Jinhong Chang; Emmanuelle Nicolas; Debora Marks; Chris Sander; Anthony Lerro; Marie Annick Buendia; Chunxiao Xu; William S Mason; Thomas Moloshok; Roque Bort; Kenneth S Zaret; John M Taylor
Journal:  RNA Biol       Date:  2004-07-01       Impact factor: 4.652

4.  Regulation of cholesterol 7 alpha-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 alpha-hydroxylase mRNA.

Authors:  Y C Li; D P Wang; J Y Chiang
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

Review 5.  Bile acid regulation of gene expression: roles of nuclear hormone receptors.

Authors:  John Y L Chiang
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

6.  Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.

Authors:  Yan Xie; Valerie Blanc; Thomas A Kerr; Susan Kennedy; Jianyang Luo; Elizabeth P Newberry; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

7.  Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes.

Authors:  Kwang-Hoon Song; Ewa Ellis; Stephen Strom; John Y L Chiang
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 8.  Bile acids: regulation of synthesis.

Authors:  John Y L Chiang
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

9.  Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1.

Authors:  Chikage Mataki; Benjamin C Magnier; Sander M Houten; Jean-Sébastien Annicotte; Carmen Argmann; Charles Thomas; Henk Overmars; Wim Kulik; Daniel Metzger; Johan Auwerx; Kristina Schoonjans
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.

Authors:  Joacim Elmén; Morten Lindow; Asli Silahtaroglu; Mads Bak; Mette Christensen; Allan Lind-Thomsen; Maj Hedtjärn; Jens Bo Hansen; Henrik Frydenlund Hansen; Ellen Marie Straarup; Keith McCullagh; Phil Kearney; Sakari Kauppinen
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  35 in total

1.  Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.

Authors:  Shu-Yun Zhang; Sailesh Surapureddi; Sherry Coulter; Stephen S Ferguson; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2012-06-20       Impact factor: 4.436

Review 2.  MicroRNAs and liver disease.

Authors:  Thomas A Kerr; Kevin M Korenblat; Nicholas O Davidson
Journal:  Transl Res       Date:  2011-02-02       Impact factor: 7.012

3.  miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.

Authors:  Gui-Xi Zheng; Ai-Lin Qu; Yong-Mei Yang; Xin Zhang; Shou-Cai Zhang; Chuan-Xin Wang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 4.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

Review 5.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

Review 6.  Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.

Authors:  Xue-Feng Jin; Ning Wu; Lv Wang; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2013-04-30       Impact factor: 5.046

Review 7.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

8.  Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration.

Authors:  Jingmin Shu; Betsy T Kren; Zhilian Xia; Phillip Y-P Wong; Lihua Li; Eric A Hanse; Michael X Min; Bingshan Li; Jeffrey H Albrecht; Yan Zeng; Subbaya Subramanian; Clifford J Steer
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

9.  Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid.

Authors:  Kyoung-Jae Won; Joo-Seop Park; Hyunyoung Jeong
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

10.  MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Andrej Besse; Robert Iliev; Jana Nekvindova; Radek Lakomy; Lenka Radova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Ondrej Slaby
Journal:  Tumour Biol       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.